Inhibitory effects of cardamonin on compound action potentials in frog sciatic nerves and the possible involvement of opioidergic pathway
Life Sciences, Medicine and Biomedicine · 2017
DOI: 10.28916/lsmb.1.1.2017.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, Medicine and Biomedicine, 2017. Verfasst von Yogesvari Sambasevam und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Introduction
Active compounds derived from plants are able to inhibit nerve conduction. Cardamonin, a naturally occurring chalcone, manifests anti-nociceptive, anti-inflammatory and anti-neuropathy properties. Consequently, cardamonin may potentially inhibit nerve action potential, whereby, it affects the nerve conduction. Compound action potential is the sum of the activity which is measured from a nerve trunk.
Objective
The study was conducted to investigate the inhibitory effect of cardamonin on compound action potentials and its possible mechanism of action on frog sciatic nerve. Methodology: Compound action potentials were recorded from frog sciatic nerve by using the AD instrument. Sciatic nerve was isolated from the frog and placed in Ringer’s solution. Stimulating electrodes were used to stimulate the nerve and recording electrodes were used to record compound action potentials. Compound action potential of the nerve were recorded before and after treatments [vehicle, cardamonin (0.5, 1 & 2 mg/ml) & morphine (3mg/ml)]. To investigate the involvement of opioidergic system, the nerve were pre-treated with naloxone and followed by cardamonin. All the data were recorded and analysed via LabTutor software. The data were analysed by using Two-way ANOVA followed by Bonferonni’s post hoc test with significant value at P < 0.05.
Results
The outcomes showed that all the doses of cardamonin significantly reduced the peak amplitude of compound action potential in frog sciatic nerves. Besides, co-treatment of naloxone and cardamonin significantly (P < 0.001) reversed the effect of cardamonin on peak amplitude of compound action potential, suggesting the involvement of opioid receptors to inhibit nerve conduction.
Conclusion
Cardamonin reduces the nerve signal conduction via activation of opioid receptors to modulate pain and contribute to the analgesic effects.
Zitieren
APA
Sambasevam, Y., Jiun, W. S., Ghazali, F. H., Ramadan, A. I. A., Farouk, A. A. O., Sulaiman, M. R., Hussain, M. K., & Perimal, E. K. (2017). Inhibitory effects of cardamonin on compound action potentials in frog sciatic nerves and the possible involvement of opioidergic pathway. Life Sciences, Medicine and Biomedicine. https://doi.org/10.28916/lsmb.1.1.2017.3
Vancouver
Sambasevam Y, Jiun WS, Ghazali FH, Ramadan AIA, Farouk AAO, Sulaiman MR, et al. Inhibitory effects of cardamonin on compound action potentials in frog sciatic nerves and the possible involvement of opioidergic pathway. Life Sciences, Medicine and Biomedicine. 2017. doi:10.28916/lsmb.1.1.2017.3
BibTeX
@article{Sambasevam2017,
author = {Sambasevam, Yogesvari and Jiun, Wong Siong and Ghazali, Farihah Hanani and Ramadan, Ammar Izzati Amir and Farouk, Ahmad Akira Omar and Sulaiman, Mohd Roslan and Hussain, Mohd Khairi and Perimal, Enoch Kumar},
title = {Inhibitory effects of cardamonin on compound action potentials in frog sciatic nerves and the possible involvement of opioidergic pathway},
journal = {Life Sciences, Medicine and Biomedicine},
year = {2017},
doi = {10.28916/lsmb.1.1.2017.3}
}
EUVIMED